NEW YORK (TheStreet) -- CHANGE IN RATINGS:
AFLAC (AFL) was downgraded at Sterne Agee to neutral from buy. Trading near 52-week highs despite negative EPS revision pressure, Sterne Agee said.
Altera (ALTR) was downgraded at Lazard Capital Markets from buy to neutral. Company faces macro growth headwinds, Lazard Capital Markets said.
TD Ameritrade (AMTD) was downgraded at Sterne Agee to neutral. $19 price target. Valuation call, as the stock is up 20% from its November lows, Sterne Agee said.American Express (AXP) was downgraded at J.P. Morgan from neutral to underweight. $60 price target. Company may struggle to regain its operating leverage, J.P. Morgan said. B/E Aerospace (BEAV) was downgraded at Deutsche from buy to hold. Valuation call, based on a $55 price target, Deutsche said. Boston Scientific (BSX) was upgraded at Credit Suisse from neutral to outperform. $7.50 price target. Sales visibility is improving, Credit Suisse said. Celgene (CELG) was upgraded at Bank of America/Merrill Lynch from neutral to buy. $115 price target. Company can deliver 25% compound annual earnings growth over the next five years, BofA/Merrill said. Cliffs Natural (CLF) was upgraded at Deutsche Bank from hold to buy. $48 price target. Sector is down, despite higher commodity prices, Deutsche said. Duke Energy (DUK) was upgraded at UBS to buy from neutral. $70 price target. Attractive risk/reward profile, UBS said. Consolidated Edison (ED) was downgraded at UBS to sell from neutral. $53 price target. New York politics leads to regulatory interference, UBS said. FMC Technologies (FTI) was upgraded at Morgan Stanley to overweight. $65 price target. Company is leveraged to better subsea processing and services demand, Morgan Stanley said. Green Mountain (GMCR) was upgraded at Argus from hold to buy. $50 price target. Company has strong brands and can benefit from higher coffee prices, Argus said. Global Payments (GPN) was initiated with a buy rating at UBS. $57 price target. Unique asset with difficult to replicate global footprint, UBS said. Hyatt Hotels (H) was initiated with an outperform rating at BMO Capital Markets. $45 price target. Strong growth potential, BMO said.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV